The Risk Continuum of Atherosclerosis and its Implications for Defining CHD by Coronary Angiography

Armin Arbab-Zadeh1, Valentin Fuster2

  • 1Department of Medicine/Cardiology Division, Johns Hopkins University, Baltimore, Maryland.

Insights

Patients with nonobstructive coronary atherosclerosis (<50% stenosis) face risks similar to obstructive disease. Current guidelines miss opportunities for secondary prevention in these millions of patients.

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Diagnostic Imaging

Background:

  • Coronary heart disease (CHD) diagnosis often relies on obstructive coronary atherosclerosis (>50% stenosis).
  • Symptomatic patients with nonobstructive coronary atherosclerosis (<50% stenosis) lack clear management guidelines.
  • Current diagnostic criteria for CHD are not met in patients with nonobstructive disease, delaying secondary preventive measures.

Purpose of the Study:

  • To highlight the risk of adverse cardiac events in patients with nonobstructive coronary atherosclerosis.
  • To emphasize the missed opportunity for secondary preventive measures in this patient population.
  • To advocate for a risk-continuous approach in diagnosing and managing coronary atherosclerosis.

Main Methods:

  • Review of available data on patients undergoing coronary angiography for suspected CHD.
  • Analysis of clinical outcomes in patients with nonobstructive coronary atherosclerosis compared to those with obstructive disease.
  • Evaluation of current clinical practice guidelines regarding nonobstructive coronary atherosclerosis management.

Main Results:

  • Patients with coronary atherosclerotic disease and <50% diameter stenosis may have similar risks of adverse cardiac events as those with single-vessel obstructive disease.
  • Millions of patients with nonobstructive coronary heart disease are potentially missing effective preventive measures.
  • Current guidelines do not provide direction for managing symptomatic patients with nonobstructive coronary atherosclerosis.

Conclusions:

  • There is a need to recognize the risk continuum of coronary atherosclerosis beyond obstructive disease.
  • Secondary preventive measures should be considered for symptomatic patients with nonobstructive coronary atherosclerosis.
  • Noninvasive coronary angiography offers an opportunity to re-evaluate CHD diagnosis and management strategies.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.4K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
677
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
679
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
860
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
357
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.7K